The risk for poor glycaemic control in patients with type 2 diabetes can be predicted with confidence by using machine learning methods, a new study from Finland finds. The most important factors predicting glycaemic control include prior glucose levels, duration of type 2 diabetes, and the patient’s existing anti-diabetic medicines.
Electronic nudges delivered to healthcare clinicians based on a machine-learning algorithm that predicts mortality risk quadrupled rates of conversations with patients about their end-of-life care preferences, according to the long-term results of a randomized clinical trial published by Penn Medicine investigators in JAMA Oncology. The study also found that the machine learning-triggered reminders significantly decreased […]
Empathy is critical to having supportive conversations about mental health. But this skill can be tricky to learn, especially in the moment when a person is sharing something that is difficult to share. A team led by researchers at the University of Washington studied how artificial intelligence could help people on the platform TalkLife < […]
The remobilization of finger joints that have been damaged by illness or injury is an emerging market in the field of demand-driven patient care. The FingerKIt consortium, which brings together five Fraunhofer institutes, uses AI to develop personalized 3D-printed joint implants so that these delicate finger parts can be replaced when necessary.
Artificial Intelligence is seeping into many aspects of our lives. As it continues to evolve exponentially its prominence in our everyday lives will become increasingly prevalent.
It has been interesting to follow the news emanating from RSNA, the world’s leading radiology event, held in Chicago recently.
Canon has decided to establish a new subsidiary, to be named Canon Healthcare USA, INC. By strengthening its presence in the highly influential American medical market, Canon aims to accelerate the growth of its medical business.
General Electric’s Board of Directors has approved the previously announced spin-off of its healthcare business, GE Healthcare Holding LLC (“GE HealthCare”). Prior to such spin-off, GE HealthCare is expected to be converted into a corporation and renamed GE HealthCare Technologies Inc. The company is expected to begin trading on Nasdaq on January 4, 2023, under […]
Nyra Medical, a medical device company that is developing a novel transcatheter mitral valve repair technology, has closed a US$20 million Series A financing round. The round was co-led by Vensana Capital and a large, global medical device company, alongside additional investors Broadview Ventures, Epidarex Capital, and the Georgia Research Alliance Venture Fund. Proceeds from […]
ONWARD Medical, a developer of therapies to restore movement, independence, and health in people with spinal cord injury, has been awarded a second grant from the European Innovation Council (EIC) to support the enhancement of an innovative Brain-Computer Interface (BCI) technology for restoring mobility and upper limb function in people with spinal cord injury.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
